摘要
人类的真菌感染可累及表皮、皮下和全身。部分表皮真菌感染可以用局部抗真菌药物治疗和预防,有些则需要进行全身治疗;皮下和全身真菌感染采取口服和静脉给药治疗m。通过对常用抗真菌药研究状况的介绍为该项研究提供思路。
参考文献5
-
1孙青龑,刘超美.抗真菌药物的研究与开发[J].药学进展,2001,25(4):213-219. 被引量:6
-
2刘潋,常海涛,屠鹏飞.抗真菌药物的研究进展[J].中国药学杂志,2001,36(4):227-230. 被引量:5
-
3封宇飞,雷静,傅德兴.新一代三唑类抗真菌药物伏立康唑[J].中国新药杂志,2003,12(1):27-29. 被引量:24
-
4盛春泉,季海涛,张万年.氮唑类抗真菌药物研究新进展[J].中国新药杂志,2002,11(4):278-281. 被引量:11
-
5顾觉奋,李治川.微生物来源的抗真菌药物[J].药学进展,2001,25(3):129-134. 被引量:3
二级参考文献61
-
1冯胜昔,徐修容.治疗全身性真菌感染药物的研究进展[J].国外医学(药学分册),1993,20(4):234-237. 被引量:4
-
2[11]Nesky MA, McDougal EC, Peacock Jr JE. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage:case report and literature review of central nervous system pseudallescheriasis[J]. Clin Infect Dis, 2000, 31:673.
-
3[12]Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia[J]. British J Haematol, 1997, 97: 663.
-
4[13]Poza G, Montoya J, Redondo C, et al. Meningitis caused by Pseudallescheria boydii treated with voriconzole[J]. Clin Infect Dis, 2000, 30: 981 - 982.
-
5[14]Louis G, Vant H, Paul E, et al. Successful treatment with voriconazole of invasion aspergillosis in chronic granulomatous disease[J]. Am J Respir Crit Care Medicine, 1998, 157: 1694.
-
6[15]Jabado N, Casanova J, Haddad E, et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children chronic granulomatous disease [J]. Clin Infect Dis, 1998, 27:1437.
-
7[1]Dickinson RP, Bell AS, Hitchcock CA, et al. Novel antifungal 2 aryl 1-(1H-1, 2, 4-triazol 1-yl)butan-2-ol derivatives with high activity against aspergillus fumigatus [J]. Bioorgan Med Chem Lett, 1996, 65: 2031.
-
8[2]Richardson K, Bell A, Dickinson R, et al. UK - 109,496, a nov el, wide-spectrum triazole derivative for the treatment of fungal infections: synthesis and SAR (abstract F69) [A]. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy[C]. San Francisco: 1995, 9: 17.
-
9[3]Sanati H, Belanger P, Fratti R, et al. A new triazole , voriconazole (UK- 109,496), blocks sterol biosynthesis in Candida albicans and Cadida krusei [J]. Antimicrob Agents Chemother,1997, 41: 2492.
-
10[4]Hoban DJ, Zhanel GG, Karlowsky JK. In vitro susceptibities of candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients[J]. Antimicrob Agents Chemother,1999, 43(6): 1463 - 1464.
共引文献43
-
1邓列华,李姝.抗真菌药物在皮肤科临床应用新进展[J].中国处方药,2005,4(3):66-69. 被引量:8
-
2徐彩丽,袁华,喻宗沅.奥美沙坦酯的研究进展[J].化学与生物工程,2005,22(4):7-8. 被引量:9
-
3李泽荣,陈仕伟,谈宁馨,陈宇综,李象远.基于支持向量学习机方法的抗真菌药物活性预测[J].高等学校化学学报,2005,26(8):1527-1531. 被引量:3
-
4李再峰,罗富英.咪唑和三唑醚类化合物的合成及生物活性[J].精细化工,2005,22(8):619-624. 被引量:2
-
5曹安民,施畅,廖明阳.唑类抗真菌药物的药理学和毒理学研究进展[J].毒理学杂志,2006,20(2):128-130. 被引量:4
-
6倪生良,沈荣明,夏平,马维恒.三唑类抗真菌药物伏立康唑的合成[J].精细石油化工,2006,23(4):33-36. 被引量:4
-
7冯碧敏,叶云.新一代三唑类抗真菌药伏立康唑的药理学性质及临床应用[J].泸州医学院学报,2006,29(4):377-379. 被引量:6
-
8曹玲华,王彩芳,陶晶.哒嗪并[3,2-c]1,2,4-三唑类化合物的合成[J].有机化学,2006,26(12):1686-1691. 被引量:3
-
9童成亮,吴小英,钟淮滨.毛细管气相色谱法测定伏立康唑中6种有机溶剂残留量[J].药物分析杂志,2006,26(12):1842-1844.
-
10王黎,李华.高效液相色谱法测定注射用伏立康唑的含量[J].西北药学杂志,2007,22(2):51-52. 被引量:2
同被引文献14
-
1曹永兵,张磊,王彦,姜远英.伏立康唑及其临床应用[J].中国新药与临床杂志,2005,24(4):330-332. 被引量:49
-
2朱继业,冷希圣.肝移植术后真菌感染[J].临床外科杂志,2006,14(6):339-339. 被引量:3
-
3侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:879
-
4中国侵袭性肺部真菌感染工作组.侵袭性肺部真菌感染的诊断标准与治疗原则(草案).待发表.
-
5Maertens J,Van Eldere J,Verhaegen P,et al.Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients[J].J Infect Dis,2002,186:1297-1306.
-
6Becker MJ,Lugtenburg E J,Cornelissen JJ,et al.Galactomannan detection in computerized tomographybased broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis[J].Br J Haematol,2003,121:448-457.
-
7Reichenberger F,Habicht JM,Gratwohl A,et al.Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients[J].Eur Respir J,2002,19 (4):743-755.
-
8Talemoto K,Yamanoto Y,Ueda Y,et al.Comparative studies on the efficacy of amBisome and fungizone in a mouse model of disseminated aspergillosis[J].J Animicrob Chemother,2004,53(2):311-317.
-
9Caillot D.Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis[J].Acta Haematol,2003,109 (3):111-118.
-
10Walsh TJ,Papps P,Winston DJ,et al.Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropeinia and persistent fever[J].N Engl J Med,2002,346 (4):225-234.
引证文献2
-
1施毅,苏欣.肺部真菌感染的药物治疗[J].继续医学教育,2006,20(2):18-23. 被引量:7
-
2戴新,石炳毅,金海龙,杜国盛,宋继勇,朱志东.肝移植术后肺部真菌感染的诊断和治疗[J].临床外科杂志,2008,16(1):34-35. 被引量:1
二级引证文献8
-
1刘神幼,杨波,张禁,周天玖.侵袭性肺部真菌感染93例临床分析[J].实用医学杂志,2007,23(17):2761-2763. 被引量:6
-
2潘伟胜,陈立朋,苏智友.支气管哮喘并肺部真菌感染24例分析[J].岭南急诊医学杂志,2008,13(5):360-361. 被引量:6
-
3刘神幼,刘力,郑红艳,张琳玲,周天玖.老年患者侵袭性肺部真菌感染的高危因素分析[J].中国综合临床,2009,25(1):57-59. 被引量:2
-
4梅湛强,罗志扬.侵袭性肺部真菌感染56例临床分析[J].中国现代医生,2009,47(28):29-30.
-
5陈颖峰,刘朝晖,覃杰.肝移植术后侵袭性肺曲菌病的CT及临床表现[J].影像诊断与介入放射学,2012,21(1):21-24. 被引量:2
-
6秦祝梅.支气管哮喘合并肺部感染64例临床治疗体会[J].世界最新医学信息文摘,2013,13(2):32-32. 被引量:1
-
7刘神幼,张琳玲,周天玖.卡泊芬净治疗老年肺部侵袭性真菌感染112例临床分析[J].实用医药杂志,2014,31(3):215-216. 被引量:3
-
8高卫卫,李培,施毅.变应性支气管肺曲霉病的临床诊治体会[J].医学研究生学报,2014,27(10):1118-1119.
-
1张建平,郭芳.妇产科抗真菌治疗进展[J].中国处方药,2006,5(3):41-44.
-
2王斌,王宏图.局部抗真菌药联苯苄唑[J].中国新药与临床杂志,1999,18(4):243-245. 被引量:16
-
3再谈抗生素滥用问题[J].癌症康复,2007(5):14-15.
-
4高敏虹,赵海生,张莉.系统抗真菌药与局部抗真菌药联合治疗甲真菌病[J].社区医学杂志,2006,4(01X):24-26.
-
5刘松青,马文秀,董慧,唐先哲,代青.高效液相色谱法测定生物样品中两性霉素B[J].中国医院药学杂志,1996,16(9):389-392. 被引量:4
-
6于波,屈毅.局部抗真菌药联苯苄唑[J].黑龙江医药,2003,16(4):306-306. 被引量:4
-
7颜喜梅.两性霉素B致静脉炎的预防[J].中国基层医药,2010,17(9):1275-1276. 被引量:1
-
8王桂臣.谈谈抗真菌药物的合理应用[J].中国医疗前沿(学术版),2008,3(10):103-104. 被引量:1
-
9李成.外用抗真菌药联苯苄唑研究概况[J].中国中医药信息杂志,2008,15(S1):122-123.
-
10杜丽娜.氟康唑[J].临床药物治疗杂志,2004,2(2):51-56.